Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.22 | 1e-09 |
mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.23 | 2e-09 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.23 | 8e-09 |
mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-07 |
mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.26 | 2e-06 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.17 | 9e-06 |
mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |